Vectored immunoprophylaxis and treatment of SARS-CoV-2 infection in a preclinical model

Vectored immunoprophylaxis was first developed as a means of establishing engineered immunity to HIV using an adenoassociated viral vector expressing a broadly neutralizing antibody. We applied this concept to establish long-term prophylaxis against severe acute respiratory syndrome coronavirus 2 (S...

Descripción completa

Detalles Bibliográficos
Autores principales: Tada, Takuya, Minnee, Julia, Landau, Nathaniel R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: National Academy of Sciences 2023
Materias:
Biological Sciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266030/
https://www.ncbi.nlm.nih.gov/pubmed/37252952
http://dx.doi.org/10.1073/pnas.2303509120

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266030/
https://www.ncbi.nlm.nih.gov/pubmed/37252952
http://dx.doi.org/10.1073/pnas.2303509120

Ejemplares similares